Free Trial

Calumet Specialty Products Partners (CLMT) to Release Quarterly Earnings on Friday

Calumet Specialty Products Partners logo with Energy background

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Friday, May 9th. Analysts expect the company to announce earnings of ($0.28) per share and revenue of $899.62 million for the quarter.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, topping the consensus estimate of ($1.06) by $0.59. The business had revenue of $949.50 million during the quarter, compared to the consensus estimate of $921.76 million. During the same quarter in the prior year, the firm posted ($0.59) EPS. The company's revenue for the quarter was down 2.8% on a year-over-year basis. On average, analysts expect Calumet Specialty Products Partners to post $-3 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Calumet Specialty Products Partners Stock Performance

CLMT stock traded up $0.56 during trading on Friday, hitting $11.25. 976,145 shares of the company's stock traded hands, compared to its average volume of 851,451. Calumet Specialty Products Partners has a 52 week low of $7.68 and a 52 week high of $25.29. The stock has a market capitalization of $969.83 million, a price-to-earnings ratio of -4.08 and a beta of 0.89. The business has a fifty day simple moving average of $11.46 and a 200 day simple moving average of $16.87.

Wall Street Analysts Forecast Growth

CLMT has been the topic of several analyst reports. HC Wainwright reissued a "buy" rating and set a $33.00 price objective on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. TD Cowen downgraded Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their price target for the stock from $26.00 to $16.00 in a research report on Tuesday, March 4th. Wells Fargo & Company cut their price objective on shares of Calumet Specialty Products Partners from $28.00 to $23.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 9th. UBS Group upgraded shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and lowered their target price for the stock from $15.00 to $12.00 in a report on Monday, March 17th. Finally, The Goldman Sachs Group reduced their price objective on shares of Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating on the stock in a research report on Wednesday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Calumet Specialty Products Partners currently has an average rating of "Hold" and a consensus target price of $19.60.

View Our Latest Analysis on Calumet Specialty Products Partners

Insider Buying and Selling at Calumet Specialty Products Partners

In related news, Director Stephen P. Mawer sold 3,655 shares of the business's stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $12.88, for a total value of $47,076.40. Following the completion of the sale, the director now owns 287,307 shares in the company, valued at approximately $3,700,514.16. The trade was a 1.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO David Lunin bought 2,500 shares of the firm's stock in a transaction on Tuesday, March 4th. The shares were purchased at an average cost of $13.05 per share, with a total value of $32,625.00. Following the completion of the transaction, the chief financial officer now owns 2,500 shares in the company, valued at $32,625. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 2.91% of the stock is owned by corporate insiders.

About Calumet Specialty Products Partners

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Recommended Stories

Earnings History for Calumet Specialty Products Partners (NASDAQ:CLMT)

Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines